NCT00060437View on ClinicalTrials.gov

Perifosine in Treating Patients With Metastatic, Androgen-Independent Prostate Cancer

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

October 31, 2003

Study Completion Date

April 30, 2004

Conditions
Prostate Cancer
Interventions
DRUG

perifosine

Trial Locations (1)

20892-1182

Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support, Bethesda

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00060437 - Perifosine in Treating Patients With Metastatic, Androgen-Independent Prostate Cancer | Biotech Hunter | Biotech Hunter